— Know what they know.
Not Investment Advice

CHEMM.CO

ChemoMetec A/S
1W: -30.4% 1M: -27.3% 3M: -64.0% YTD: -32.1% 1Y: -50.4% 3Y: -55.0% 5Y: -46.0%
kr 298.00 ($45.98)
+17.40 (+6.20%)
 
CPH · Healthcare · Medical - Devices · kr 4.9B · Alpha Radar Sell · Power 32
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Capkr 4.9B ($753.5M)
52W Range240.8-804
Volume505,915
Avg Volume63,918
Beta1.21
Dividendkr 7.00
Analyst Ratings
No analyst coverage
Company Info
CEOMartin Helbo Behrens
Employees184
SectorHealthcare
IndustryMedical - Devices
IPO Date2006-12-18
Gydevang 43
Allerød 3450
DK
45 48 13 10 20
About ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal production; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. It also provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. The company was incorporated in 1997 and is headquartered in Allerød, Denmark.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms